Shingles vaccine update

Shingles Vaccine Update Recent studies highlight vaccine benefits. A recent Kaiser Permanente study has shown that the shingle vaccine (Zostavax) reduces the risk of contracting the rash by 55% in patients age 60 and older.   The study also found that the vaccine reduced the risk of ophthalmic by 63%.  The vaccine costs about $150. […]